High MicroRNA-370 Expression Correlates with Tumor Progression and Poor Prognosis in Breast Cancer

Purpose Deregulation of microRNA-370 (miR-370) has been reported in various cancers, in which it can act as either an oncogene or a tumor suppressor gene. However, the clinicopathologic significance of miR-370 expression in breast cancer has not been studied. Methods The expression of miR-370 was determined with quantitative real-time polymerase chain reaction in 60 formalin-fixed, paraffin-embedded primary breast cancer tissues. Additionally, the protein expression levels of previously known targets of miR-370, such as FOXM1, FOXO1, and FOXO3a, were detected using immunohistochemistry. Finally, we analyzed its correlation with target protein expression, clinicopathologic features, and clinical outcome. Results High levels of miR-370 expression correlated with lymph node metastasis (p=0.009), advanced stage (p=0.002), and frequent perineural invasion (p=0.042). Moreover, patients with high miR-370 expression had poor disease-free survival compared with the low-expression group. However, no correlation was observed between miR-370 and its target protein expression. Conclusion Our results indicate that upregulation of miR-370 in breast cancer is correlated with breast cancer progression and that it might be a potential biomarker for predicting clinical outcomes.

[1]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[2]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[3]  J. Yang,et al.  MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene , 2014, Oncogene.

[4]  Christophe Lemetre,et al.  MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer , 2009, Breast Cancer Research.

[5]  C.-H. Wu,et al.  miR-370 modulates insulin receptor substrate-1 expression and inhibits the tumor phenotypes of oral carcinoma. , 2013, Oral diseases.

[6]  C. Sotiriou,et al.  Global MicroRNA Expression Profiling Identifies MiR-210 Associated with Tumor Proliferation, Invasion and Poor Clinical Outcome in Breast Cancer , 2011, PloS one.

[7]  Liu Wenming,et al.  miR-370 targeted FoxM1 functions as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC). , 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[8]  Leonard D. Goldstein,et al.  MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype , 2007, Genome Biology.

[9]  Xiangming Yan,et al.  Stat3 inhibits WTX expression through up‐regulation of microRNA‐370 in Wilms tumor , 2013, FEBS letters.

[10]  E. Lam,et al.  FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer , 2011, Oncogene.

[11]  Crispin J. Miller,et al.  Enhanced stability of microRNA expression facilitates classification of FFPE tumour samples exhibiting near total mRNA degradation , 2012, British Journal of Cancer.

[12]  H. Feilotter,et al.  An array-based analysis of microRNA expression comparing matched frozen and formalin-fixed paraffin-embedded human tissue samples. , 2008, The Journal of molecular diagnostics : JMD.

[13]  H. Kantarjian,et al.  Acute myeloid leukemia , 2018, Methods in Molecular Biology.

[14]  Xiaoming Wang,et al.  MiR-370 sensitizes chronic myeloid leukemia K562 cells to homoharringtonine by targeting Forkhead box M1 , 2013, Journal of Translational Medicine.

[15]  John W M Martens,et al.  Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer , 2008, Proceedings of the National Academy of Sciences.

[16]  Jiping Zeng,et al.  The tumor suppressive role of miRNA-370 by targeting FoxM1 in acute myeloid leukemia , 2012, Molecular Cancer.

[17]  Victor Trevino,et al.  SurvMicro: assessment of miRNA-based prognostic signatures for cancer clinical outcomes by multivariate survival analysis , 2014, Bioinform..

[18]  W. Cong,et al.  Perturbation of MicroRNA‐370/Lin‐28 homolog A/nuclear factor kappa B regulatory circuit contributes to the development of hepatocellular carcinoma , 2013, Hepatology.

[19]  Pei-ying Zhang,et al.  MicroRNA-10b targets E-cadherin and modulates breast cancer metastasis , 2012, Medical science monitor : international medical journal of experimental and clinical research.

[20]  Lei Zhang,et al.  Upregulation of miR-370 contributes to the progression of gastric carcinoma via suppression of FOXO1. , 2013, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[21]  X. Mao,et al.  Upregulation of MircoRNA-370 Induces Proliferation in Human Prostate Cancer Cells by Downregulating the Transcription Factor FOXO1 , 2012, PloS one.

[22]  Peter S Linsley,et al.  MicroRNAs and Cell Cycle Regulation , 2007, Cell cycle.

[23]  Jiping Zeng,et al.  FoxM1 is Overexpressed in Helicobacter pylori–Induced Gastric Carcinogenesis and Is Negatively Regulated by miR-370 , 2013, Molecular Cancer Research.

[24]  Xiaowei Xu,et al.  MicroRNA isolation from formalin-fixed, paraffin-embedded tissues. , 2011, Methods in molecular biology.

[25]  G. Lutz,et al.  Nanopolymers improve delivery of exon skipping oligonucleotides and concomitant dystrophin expression in skeletal muscle of mdx mice , 2008, BMC biotechnology.

[26]  M. Odero,et al.  Integration of SNP and mRNA Arrays with MicroRNA Profiling Reveals That MiR-370 Is Upregulated and Targets NF1 in Acute Myeloid Leukemia , 2012, PloS one.

[27]  S. Lo,et al.  Overexpression of miR-370 and downregulation of its novel target TGFβ-RII contribute to the progression of gastric carcinoma , 2012, Oncogene.